| Dalbavancin for the Treatment of Acute Bacterial Skin and Skin Structure Infections in Children, Known or Suspected to be Caused by Susceptible Gram-positive Organisms, Including MRSA (NCT02814916) | AbbVie | 2017-03-30 |
| Patient-Centered Comparative Effectiveness Research (CER) Study of Home-based Interventions to Prevent CA-MRSA Infection Recurrence (NCT02566928) | Clinical Directors Network | 2015-10-01 |
| Clinical and Economic Outcomes of Ceftaroline Fosamil for ABSSSI Documented or at Risk of MRSA (NCT02582203) | Wayne State University | 2012-02-01 |
| Daptomycin Versus Vancomycin in Participants With Skin Infections Due to MRSA (NCT01419184) | Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | 2011-09-09 |
| Methicillin-resistant Staphylococcus Aureus (MRSA) Skin and Soft Tissue Infection (SSTI) Prevention in Military Trainees (NCT01105767) | Henry M. Jackson Foundation for the Advancement of Military Medicine | 2010-05-01 |
| An Evaluation Of Three Dose Levels Of 3-Antigen Staphylococcus Aureus Vaccine (SA3Ag) In Healthy Adults (NCT01018641) | Pfizer | 2010-01-01 |
| Staphylococcus Aureus Decolonization Study (NCT00731783) | Washington University School of Medicine | 2008-07-01 |
| Safety and Efficacy Study of a Fluoroquinolone to Treat Complicated Skin Infections (NCT00719810) | Melinta Therapeutics, Inc. | 2008-06-01 |
| A Complicated Skin and Soft-tissue Infection Patient Registry (NCT00737269) | Ortho-McNeil Janssen Scientific Affairs, LLC | 2008-06-01 |
| Safety and Efficacy Study of Oxazolidinones to Treat Uncomplicated Skin Infections (NCT00646958) | Melinta Therapeutics, Inc. | 2007-12-01 |
| A Study Evaluating the Pharmacokinetics of Ceftobiprole When Taken by Obese Patients (NCT01026558) | Basilea Pharmaceutica | 2007-08-01 |
| A Study for Patients With Complicated Skin and Skin Structure Infections (NCT00514527) | Targanta Therapeutics Corporation | 2007-08-01 |
| A Single-Dose Pharmacokinetics and Safety Study of Ceftobiprole in Pediatric Patients =3 Months to <18 Years of Age (NCT01026636) | Basilea Pharmaceutica | 2007-08-01 |
| First Time in Man Trial for Friulimicin B (NCT00492271) | MerLion Pharmaceuticals GmbH | 2007-06-01 |
| Evaluation of Penetration of Ceftobiprole Into Soft Tissue Determined by Microdialysis in Healthy Volunteers (NCT01026740) | Basilea Pharmaceutica | 2007-06-01 |
| Chlorhexidine Impregnated Cloths to Prevent Skin and Soft Tissue Infections in Marine Officer Candidates (NCT00475930) | Henry M. Jackson Foundation for the Advancement of Military Medicine | 2007-05-01 |
| The Natural History of Community-Associated MRSA Infections and Decolonization Strategies (NCT00513799) | Washington University School of Medicine | 2007-03-01 |
| Safety and Efficacy of Daptomycin for the Treatment of Complicated Skin and Skin-structure Infections (NCT00463801) | Novartis | 2007-01-01 |
| Ceftobiprole in the Treatment of Resistant Staphylococcus Aureus Skin and Skin Structure Infections (NCT00210899) | Basilea Pharmaceutica | 2005-09-01 |
| Ceftobiprole in the Treatment of Resistant Staphylococcus Aureus Skin and Skin Structure Infections (NCT00228982) | Basilea Pharmaceutica | 2004-10-01 |